Viewing Study NCT01008995


Ignite Creation Date: 2025-12-24 @ 1:49 PM
Ignite Modification Date: 2026-01-27 @ 5:12 AM
Study NCT ID: NCT01008995
Status: COMPLETED
Last Update Posted: 2013-11-11
First Post: 2009-11-05
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: A Study of the Safety and Effectiveness of Ustekinumab (Stelara) in Chinese Patients With Psoriasis
Sponsor: Centocor, Inc.
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Psoriasis View
Keywords:

Keywords

Keyword Brief Keyword Text View
None psoriasis View
None asian patients View
None Chinese View
None ustekinumab View
None CNTO 1275 View
None Stelara View